Osaic Holdings’s Acceleron Pharma XLRN Stock Holding History

Osaic Holdings’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,075	Closed	-$1.39M	–	7823
2021 Q3	$1.39M	Buy	8,075 +4,229	+110%	+$553K	﹤0.01%	2047
2021 Q2	$483K	Buy	3,846 +1,935	+101%	+$244K	﹤0.01%	3067
2021 Q1	$259K	Buy	1,911 +736	+63%	+$95.1K	﹤0.01%	3516
2020 Q4	$151K	Sell	1,175 -26	-2%	-$3.05K	﹤0.01%	3735
2020 Q3	$132K	Buy	1,201 +739	+160%	+$73.6K	﹤0.01%	3602
2020 Q2	$43K	Sell	462 -208	-31%	-$20.1K	﹤0.01%	4297
2020 Q1	$60K	Buy	+670	New	+$52.1K	﹤0.01%	3848

Osaic Holdings's XLRN Position: Q4 2021 in Review

Osaic Holdings sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 8,075 shares — an estimated $1.39M sold.

Osaic Holdings first reported a position in XLRN in Q1 2020 and held it in 7 quarters. The position peaked at $1.39M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Osaic Holdings reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Osaic Holdings sold 8,075 Acceleron Pharma shares in Q4 2021, an estimated $1.39M.
Osaic Holdings first reported a position in Acceleron Pharma in Q1 2020 and held it in 7 quarters.
Osaic Holdings's Acceleron Pharma position peaked at $1.39M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.